These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


283 related items for PubMed ID: 10422348

  • 1. [Chiral compounds and their pharmacologic effects].
    Slováková A, Hutt AJ.
    Ceska Slov Farm; 1999 May; 48(3):107-12. PubMed ID: 10422348
    [Abstract] [Full Text] [Related]

  • 2. Three-dimensional view of pharmacology.
    Wainer IW.
    Am J Hosp Pharm; 1992 Sep; 49(9 Suppl 1):S4-8. PubMed ID: 1530004
    [Abstract] [Full Text] [Related]

  • 3. Application of thin-layer chromatography in enantiomeric chiral analysis-an overview.
    Aboul-Enein HY, El-Awady MI, Heard CM, Nicholls PJ.
    Biomed Chromatogr; 1999 Dec; 13(8):531-7. PubMed ID: 10611607
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Stereoselectivity in drug metabolism.
    Lu H.
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):149-58. PubMed ID: 17428147
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Chirality and drugs].
    Testa B, Reist M, Carrupt PA.
    Ann Pharm Fr; 2000 Jul; 58(4):239-46. PubMed ID: 10915971
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Preparations and biological properties of chiral compounds].
    Sinko G.
    Arh Hig Rada Toksikol; 2005 Dec; 56(4):351-61. PubMed ID: 16370519
    [Abstract] [Full Text] [Related]

  • 12. Chirality and its implications in transdermal drug development.
    Reddy IK, Kommuru TR, Zaghloul AA, Khan MA.
    Crit Rev Ther Drug Carrier Syst; 2000 Dec; 17(4):285-325. PubMed ID: 10958245
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chirality in ocular agents.
    Leonov A, Bielory L.
    Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):418-23. PubMed ID: 17873582
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The strategy of enantiomer patents of drugs.
    Agranat I, Wainschtein SR.
    Drug Discov Today; 2010 Mar; 15(5-6):163-70. PubMed ID: 20116449
    [Abstract] [Full Text] [Related]

  • 18. [Stereochemistry--an overlooked problem in medical treatment and research].
    Mikkelsen EO.
    Ugeskr Laeger; 1990 Jul 09; 152(28):2029-32. PubMed ID: 2195737
    [Abstract] [Full Text] [Related]

  • 19. Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics.
    Brocks DR.
    Biopharm Drug Dispos; 2006 Nov 09; 27(8):387-406. PubMed ID: 16944450
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.